Risk factors for and outcomes of patients with POEMS syndrome who experience progression after first-line treatment

Kourelis TV, Buadi FK, Kumar SK, et al.

Am J Hematol · 2016

Key Findings

  • 5-year PFS 58%, 5-year OS 78%
  • 30% experienced relapse/progression
  • Median time to relapse/progression 42 months
  • Complete hematologic response associated with PFS of 88%

Referenced in (1 disease)

Validation history

Full log →
  1. passsource metadataJun 1, 2026, 04:40 PMby pubmed-api

    Stored DOI was incorrect; corrected to the PubMed-registered DOI (verified to resolve to this article).

    tools: pubmed.esummary, crossref.works

ID: pmid-26669974DOI: 10.1038/leu.2015.344PMID: 26669974